Newswire (Published: Monday, July 1, 2019, Received: Monday, July 1, 2019, 3:42:55 PM CDT)

Word Count: 385

2019 JUL 01 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Current study results on Oncology - Prostate Cancer have been published. According to news reporting from Beirut, Lebanon, by NewsRx journalists, research stated, “Chemotherapy in prostate cancer (PCa) has undergone dramatic landscape changes. While earlier studies utilized varying chemotherapy regimens which were found to be largely palliative in nature and hardly resulted in durable or meaningful responses, docetaxel resulted in the first chemotherapy agent that showed improvement in overall survival in metastatic castration-resistant prostate cancer (mCRPC).”

The news correspondents obtained a quote from the research from Lebanese American University, “However, combination chemotherapy or any agents added to docetaxel have failed to yield incremental benefits. The improvement in overall survival as well as secondary endpoints of prostate-specific antigen (PSA) and time to recurrence when using docetaxel in the metastatic hormone-sensitive state has changed the standard of care for treatment of newly diagnosed de novo metastatic PCa. There are also promising results in locally advanced PCa and high-risk PCa in both the neoadjuvant and adjuvant settings.”

According to the news reporters, the research concluded: “This review summarizes the historical as well as the more contemporary use of chemotherapeutic agents in PCa in varying states and phases of disease.”

For more information on this research see: Role of chemotherapy in prostate cancer. Asian Journal of Andrology, 2018;20(3):221. Asian Journal of Andrology can be contacted at: Blackwell Publishing Inc, 350 Main St, Malden, MA 02148, USA. (Nature Publishing Group - http://www.nature.com/; Asian Journal of Andrology - http://www.nature.com/aja/)

Our news journalists report that additional information may be obtained by contacting R. Nader, Dept. of Internal Medicine, American University, Beirut 1102 2801, Lebanon. Additional authors for this research include J. El Amm and J.B Aragon-Ching.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.4103/aja.aja_40_17. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the Asian Journal of Andrology is: Blackwell Publishing Inc, 350 Main St, Malden, MA 02148, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Companies

Lebanese American University

Industries

Information and Media
      Publishing

Places

North America
Western Asia
Lebanon
United States
Americas
Asia
Massachusetts
Beirut
Malden

Subjects

Science and Technology
      Scientific Research
            Medical Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Health Sciences
            Medical Research
      Treatments and Therapies
            Chemotherapy